Elon’s New Device is About to Shock the World

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

Walter M. Rosenbrough, Jr. net worth and biography

Walter Rosenbrough, Jr. Biography and Net Worth

CEO of STERIS

Walt Rosebrough has been president and chief executive officer of STERIS and a member of its Board of Directors since October 1, 2007. STERIS is a leading provider of infection prevention and procedural products and services, focused primarily on healthcare, pharmaceutical and medical device companies.

He has held leadership positions in most major business functions, including product and business development, manufacturing, finance, and marketing. He has led ventures ranging in scale from start-up operations to multi-billion dollar, multinational businesses with thousands of employees.

Mr. Rosebrough has been an executive in the healthcare industry over 30 years, and CEO for over 25 years. He served as CEO of Support Systems International (SSI), a leading provider of equipment and services to relieve complications of immobility. After the merger of SSI and Hill-Rom, he was named CEO of Hill-Rom, a global leader in patient support systems, therapeutic products, and workflow information technology.

What is Walter M. Rosenbrough, Jr.'s net worth?: The estimated net worth of Walter M. Rosenbrough, Jr. is at least $16.52 million as of November 6th, 2020. Mr. Rosenbrough, Jr. owns 71,405 shares of STERIS stock worth more than $16,518,119 as of May 12th. This net worth approximation does not reflect any other assets that Mr. Rosenbrough, Jr. may own. Learn More about Walter M. Rosenbrough, Jr.'s net worth.
How do I contact Walter M. Rosenbrough, Jr.?: The corporate mailing address for Mr. Rosenbrough, Jr. and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Walter M. Rosenbrough, Jr.'s contact information.
Has Walter M. Rosenbrough, Jr. been buying or selling shares of STERIS?: Walter M. Rosenbrough, Jr. has not been actively trading shares of STERIS during the past quarter. Most recently, Walter M. Rosebrough, Jr. sold 10,000 shares of the business's stock in a transaction on Friday, November 6th. The shares were sold at an average price of $181.39, for a transaction totalling $1,813,900.00. Following the completion of the sale, the chief executive officer now directly owns 71,405 shares of the company's stock, valued at $12,952,152.95. Learn More on Walter M. Rosenbrough, Jr.'s trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 5/15/2023.

Walter M. Rosenbrough, Jr. Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2020	Sell	10,000	$181.39	$1,813,900.00	71,405
8/8/2019	Sell	102,500	$151.78	$15,557,450.00
5/31/2019	Sell	119,000	$132.56	$15,774,640.00
3/21/2019	Sell	50,000	$125.00	$6,250,000.00	98,895
11/7/2018	Sell	10,000	$120.50	$1,205,000.00
7/13/2018	Sell	10,000	$110.50	$1,105,000.00
6/1/2018	Sell	8,571	$104.46	$895,326.66	61,192
5/29/2018	Sell	10,697	$102.91	$1,100,828.27	52,573
5/9/2018	Sell	10,000	$100.50	$1,005,000.00
3/12/2018	Sell	10,000	$95.50	$955,000.00
10/4/2017	Sell	10,000	$90.50	$905,000.00
8/16/2017	Sell	10,000	$85.69	$856,900.00	83,270
6/2/2017	Sell	10,000	$80.05	$800,500.00
8/17/2016	Sell	15,000	$71.08	$1,066,200.00
2/17/2016	Sell	10,000	$64.27	$642,700.00
11/18/2015	Sell	11,960	$75.58	$903,936.80	111,376
9/30/2015	Sell	5,000	$64.92	$324,600.00	116,376
9/29/2015	Sell	10,000	$64.43	$644,300.00	121,376
6/10/2015	Sell	20,000	$63.80	$1,276,000.00
6/9/2015	Sell	5,000	$63.56	$317,800.00
5/30/2013	Sell	2,000	$45.72	$91,440.00

Walter M. Rosenbrough, Jr. Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $231.33

$223.68

$231.74

50 Day Range

MA: $216.99

$198.94

$233.84

2 Week Range

Now: $231.33

$195.47

$254.00

Volume

867,834 shs

Average Volume

606,704 shs

Market Capitalization

$22.86 billion

P/E Ratio

60.56

Dividend Yield

0.92%

Beta

0.81